Grail, Inc. GRAL
$59.60
▼ -0.52% 24H
About
Grail, Inc. is a biotechnology company headquartered in Menlo Park, California, founded in 2015. The company focuses on alleviating the global burden of cancer through innovative multi-cancer early detection technologies. Its flagship product, the Galleri test, is a blood-based liquid biopsy that screens for multiple d…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees910
TickerGRAL
Statistics
Market Cap$2.45B
Revenue (TTM)$147.2M
Net Income-$408.4M
Net Margin-277.5%
EPS$-11.11
P/E-5.37
P/S16.64
P/B1.00
EV/EBITDA-4.83
ROE-16.1%
Dividend Yield—
Price$59.60
Data: Twelve Data · Revenue = mcap / P/S